2020
Incidence trends of esophageal cancer in the Czech Republic by histological subtype and stage and prescription rate of acid suppressing drugs
KROUPA, Radek, Ivana KATINOVÁ, Tomáš PAVLÍK, Lumír KUNOVSKÝ, Vladimír PROCHÁZKA et. al.Základní údaje
Originální název
Incidence trends of esophageal cancer in the Czech Republic by histological subtype and stage and prescription rate of acid suppressing drugs
Autoři
KROUPA, Radek (203 Česká republika, garant, domácí), Ivana KATINOVÁ (203 Česká republika, domácí), Tomáš PAVLÍK (203 Česká republika, domácí), Lumír KUNOVSKÝ (203 Česká republika, domácí), Vladimír PROCHÁZKA (203 Česká republika, domácí), Petra BOŘILOVÁ LINHARTOVÁ (203 Česká republika, domácí), Barbora PACKOVÁ (203 Česká republika, domácí), Zdeněk KALA (203 Česká republika, domácí) a Jiří DOLINA (203 Česká republika, domácí)
Vydání
Cancer epidemiology, Oxford, Elsevier, 2020, 1877-7821
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.984
Kód RIV
RIV/00216224:14110/20:00120084
Organizační jednotka
Lékařská fakulta
UT WoS
000596559500014
Klíčová slova anglicky
Esophageal cancer; Esophageal adenocarcinoma; Squamous cell carcinoma; Proton pump inhibitor; Gastroesophageal reflux disease
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 19. 1. 2021 13:57, Mgr. Tereza Miškechová
Anotace
V originále
Background: Incidence of esophageal adenocarcinoma (EAC) associated with gastroesophageal reflux disease has increased substantially in developed countries during the past decades. We aimed to analyze trends in incidence of esophageal cancer (EC) by histological subtypes and trends in acid suppressing drugs prescription in the Czech Republic. Methods: The incidence of EC by histological subtypes, sex, and stage from 1984-2017 was examined using data from the Czech National Cancer Registry. Defined daily doses of acid inhibiting drugs were analyzed from annual reports by the State Institute for Drug Control. Results: Age standardized incidence of EAC in men increased annually by 4.88 % with 95 % confidence interval (CI) (4.32, 5.45) from 1984 to 2017, and by 5.11 % (95 % CI, 4.02, 6.20) in women. Squamous cell carcinoma increased annually by 5.52 % (95 % CI, 2.49, 8.64) from 1984 to 1994 with subsequent slower increase by 0.87 % (95 % CI, 0.25, 1.50) from 1994 to 2017. It still represents 50 % of all EC in 2017. The comparable early stages of EAC showed similar annual percentage change of 5.77 %. From 2001 to 2018 the use of proton pump inhibitors increased dramatically from 6.8 to 72.9 defined daily doses per 1000 inhabitants. Conclusion: The incidence of EAC is still increasing in the Czech Republic, however it represents less than half of ECs. The incidence of squamous cell carcinoma is relatively stable. Broad use of acid suppressing drugs did not seem to impact the incidence of EAC even in early stages.
Návaznosti
NU20-03-00126, projekt VaV |
|